Orient EuroPharma Statistics

Total Valuation

TPEX:4120 has a market cap or net worth of TWD 4.27 billion. The enterprise value is 7.55 billion.

Market Cap	4.27B
Enterprise Value	7.55B

Important Dates

The last earnings date was Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4120 has 86.75 million shares outstanding. The number of shares has decreased by -0.23% in one year.

Current Share Class	n/a
Shares Outstanding	86.75M
Shares Change (YoY)	-0.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.62%
Owned by Institutions (%)	1.38%
Float	32.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.97
PB Ratio	0.83
P/TBV Ratio	0.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 43.74, with an EV/FCF ratio of -34.30.

EV / Earnings	-26.60
EV / Sales	1.72
EV / EBITDA	43.74
EV / EBIT	n/a
EV / FCF	-34.30

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.73.

Current Ratio	1.20
Quick Ratio	0.75
Debt / Equity	0.73
Debt / EBITDA	21.15
Debt / FCF	-19.21
Interest Coverage	-0.06

Financial Efficiency

Return on equity (ROE) is -4.63% and return on invested capital (ROIC) is -0.04%.

Return on Equity (ROE)	-4.63%
Return on Assets (ROA)	-0.04%
Return on Invested Capital (ROIC)	-0.04%
Return on Capital Employed (ROCE)	-0.08%
Revenue Per Employee	12.95M
Profits Per Employee	-837,563
Employee Count	339
Asset Turnover	0.39
Inventory Turnover	2.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.70% in the last 52 weeks. The beta is 0.43, so TPEX:4120's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+12.70%
50-Day Moving Average	50.97
200-Day Moving Average	48.80
Relative Strength Index (RSI)	40.98
Average Volume (20 Days)	68,571

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4120 had revenue of TWD 4.39 billion and -283.93 million in losses. Loss per share was -3.27.

Revenue	4.39B
Gross Profit	2.07B
Operating Income	-6.72M
Pretax Income	-129.99M
Net Income	-283.93M
EBITDA	153.46M
EBIT	-6.72M
Loss Per Share	-3.27

Full Income Statement

Balance Sheet

The company has 1.61 billion in cash and 4.23 billion in debt, giving a net cash position of -2.62 billion or -30.20 per share.

Cash & Cash Equivalents	1.61B
Total Debt	4.23B
Net Cash	-2.62B
Net Cash Per Share	-30.20
Equity (Book Value)	5.82B
Book Value Per Share	59.53
Working Capital	667.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -121.11 million and capital expenditures -99.06 million, giving a free cash flow of -220.16 million.

Operating Cash Flow	-121.11M
Capital Expenditures	-99.06M
Free Cash Flow	-220.16M
FCF Per Share	-2.54

Full Cash Flow Statement

Margins

Gross margin is 47.05%, with operating and profit margins of -0.15% and -6.47%.

Gross Margin	47.05%
Operating Margin	-0.15%
Pretax Margin	-2.96%
Profit Margin	-6.47%
EBITDA Margin	3.49%
EBIT Margin	-0.15%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.03%.

Dividend Per Share	1.00
Dividend Yield	2.03%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	0.23%
Shareholder Yield	2.26%
Earnings Yield	-6.65%
FCF Yield	-5.15%

Dividend Details

Stock Splits

The last stock split was on July 28, 2010. It was a forward split with a ratio of 1.16.

Last Split Date	Jul 28, 2010
Split Type	Forward
Split Ratio	1.16

Scores

TPEX:4120 has an Altman Z-Score of 1.1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.1
Piotroski F-Score	n/a